发明名称 |
Methods for predicting the efficacy or outcome of hcv therapy |
摘要 |
The present invention relates to a novel method for predicting likeliness of the outcome or efficacy of an antiviral therapy against Hepatitis C Virus (HCV). This method is based on the detection of antibodies against the proteins NSta and or NS5a in a sample of a patient. This method can be further combined with the detection of viral titers of HCV in a sample of a patient. The method of the invention allows a more reliable identification of a subset of non-responders in an early stage of treatment.
|
申请公布号 |
US2007166702(A1) |
申请公布日期 |
2007.07.19 |
申请号 |
US20050572200 |
申请日期 |
2005.07.18 |
申请人 |
LEROUX-ROELS GEERT;DESOMBERE ISABELLE |
发明人 |
LEROUX-ROELS GEERT;DESOMBERE ISABELLE |
分类号 |
C12Q1/70 |
主分类号 |
C12Q1/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|